NSG Ventures
Venture capitalSingapore · Seed–Series A · 10 people tracked
Investment thesis
NSG Ventures focuses on biotechnology and the treatment of human disease, investing in innovative scientific solutions to major health problems. Managed by founders and scientists, the firm partners with exceptional teams for the long term to push scientific boundaries and enable medical breakthroughs.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & curated & public directoriesFounder mafia
2 people who came through NSG Ventures went on to found or lead other companies.
What they invest in
from 15 of 25 portfolio companiesBiotech ×12Deep Tech ×7AI & Machine Learning ×5Medical Devices ×4Digital Health ×2Healthtech ×2PropTech ×2Advanced Manufacturing ×1
HQs:United States×4Singapore×3China×1United Kingdom×1
Investments · 25 tracked
founders shown can be your intro pathBiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security.
AI & Machine LearningBiotechCybersecurityDeep TechDefense TechHardware
Jonathan Solomon(Chief Executive Officer)Merav Bassan(Chief Development Officer)Marina Wolfson(Chief Financial Officer)Jesse Goodman(Director)Alan Moses(Director)Jonathan Leff(Director)
Co-investorsAMR Action FundBaruch Future VenturesOrbiMed8VC
Co-investorsLAVLilly Asia VenturesNew Enterprise Associates (NEA)Nextech Invest
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)Kanya Rajangam(President, Head of Research & Development and Chief Medical Officer)Yvonne Li(Executive Officer)James Collins(Director)
BoardDonald Tang(Director)
Co-investorsEvolution VC PartnersFlucas VenturesLifeforce CapitalLux CapitalMenlo VenturesNew Enterprise Associates (NEA)+2 more
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.
BiotechDeep TechMedical DevicesCambridge, US
Bharatt Chowrira(Executive Officer)Michael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)Paul Miller(Executive Officer)Aoife Brennan(Executive Officer)Todd Shegog(Executive Officer)
Co-investorsAtlas VentureNew Enterprise Associates (NEA)Pfizer Venture InvestmentsSofinnova VenturesSolasta VenturesOrbiMed
Tango Therapeutics develops genetically targeted medicines using synthetic lethality principles to treat specific tumors.
BiotechBoston, US
Alan Huang(Executive Officer)Adam Crystal(Executive Officer)Daniella Beckman(Executive Officer)Douglas Barry(Executive Officer)Aaron Davis(Director)
BoardBarbara Weber(Executive Officer, Director)in
Co-investorsForesite CapitalNextech InvestThird Rock Ventures
Biotix develops natural, sustainable skincare ingredients derived from skin microbiome microbes, using an AI platform alongside biology experiments to identify and test ingredients for efficacy and safety.
AI & Machine LearningBiotechWellness & Fitness
Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.
Advanced ManufacturingBiotechDeep TechFoodTechNew Materials
Dr. Cheryl Cui(CEO)
Co-investorsHongShan Capital GroupSource Code CapitalMatrix Partners ChinaSherpa Healthcare Partners
Cognito Health is a medical device manufacturer that uses predictive algorithms to provide contact-free patient monitoring, forecasting adverse events such as falls and pressure injuries before they occur.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Jeff Swartzin
Co-investorsAcre Venture PartnersCanaan PartnersCultivian Sandbox Ventures
Eligo Bio works on the role of bacterial genes in triggering or worsening disease, applying genetic causality across a range of therapeutic areas.
BiotechDeep TechHealthtech
Co-investorsSanofi VenturesVIVES Partners
Engine Bio presents itself as a company working on new cancer medicines.
BiotechSingapore, SG
Daphne Teo(Founder)
Foundation Medicine is a precision medicine company that develops comprehensive genomic profiling and companion diagnostic tests for cancer and other diseases.
BiotechDigital HealthMedical DevicesBoston, US
Co-investorsGV (Google Ventures)Khosla VenturesKleiner Perkins
Medra builds robotic systems integrated with AI, computer vision, and natural language processing to automate data collection for life science research.
AI & Machine LearningBiotechDeep TechRobotics
Michelle Lee(Co-founder)in
Co-investorsCarbon SiliconFifty YearsFusionHuman CapitalLux CapitalMenlo Ventures+4 more
NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D.
BiotechPropTechSingapore, SG
Daphne Teo(Founder)
Co-investorsClavystBio
OpenProtein.AI offers protein language models and AI infrastructure for protein engineering, covering de novo sequence design, variant effect prediction, in silico screening, and training specialized models on proprietary data.
AI & Machine LearningBiotechDeep Tech
Tristan Bepler
ZUZU Hospitality provides property management software and revenue management tools for independent hotels, combining automated pricing, distribution across OTAs, and reservation management with human expertise.
PropTechSaaSTravel & HospitalitySingapore, SG
Co-investorsAC VenturesGolden Gate VenturesLatin LeapVulpes VenturesWavemaker PartnersZ Venture Capital+2 more
Exits · 5
IPOs and acquisitions across the tracked portfolioBiomXNYSE: PHGEBlack Diamond Therapeutics, IncNASDAQ: BDTXSenti BiosciencesNASDAQ: SNTISynlogicOTC: SYBXTango TherapeuticsNASDAQ: TNGX
Portfolio news
latest coverage across their companiesBiomX · stocktitan.net · Aug 14, 2026
Senti Biosciences · kalkine.com.au · Jul 31, 2026
Tango Therapeutics · investing.com · Jul 17, 2026
Medra · hlth.com · Dec 15, 2025
Frequently asked questions
- How many investments has NSG Ventures made?
- NSG Ventures has 27 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does NSG Ventures invest at?
- NSG Ventures invests at the Seed, Series A stages.
- What sectors does NSG Ventures focus on?
- NSG Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is NSG Ventures located?
- NSG Ventures is headquartered in Singapore, SG.
- Who does NSG Ventures co-invest with?
- NSG Ventures most often shares deals with New Enterprise Associates (NEA), Lux Capital, Menlo Ventures, among 51 tracked co-investors.
Images
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

















.jpeg)
